RLMD

Relmada Therapeutics Inc

• Benzinga·09/29 21:06

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• Seeking Alpha·09/14 18:50

  Relmada: 'Hold' Based On Needed NVD-01 Manufacturing Push For IND YE2026 And Sepranolone Advancement

• NASDAQ·09/14 13:30

  5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

• TipRanks·09/12 02:04

  Top Brass Double Down on Relmada Therapeutics in Bold Insider Bet

• NASDAQ·09/11 17:32

  Friday 9/11 Insider Buying Report: RLMD, CELH

• Benzinga·09/11 12:06

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• TipRanks·09/08 12:34

  Relmada Therapeutics Announces Urology Chief Medical Officer Exit

• TipRanks·09/02 16:30

  Relmada’s NDV-01 Bladder Cancer Trial Moves Into Phase 3: What Investors Should Watch

• NASDAQ·08/27 20:37

  Relmada Therapeutics is Now Oversold (RLMD)

• TipRanks·08/13 00:28

  Relmada Therapeutics Earnings Call Highlights NDV-01 Path

• TipRanks·08/11 18:10

  Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

• TipRanks·08/07 15:27

  Piper Sandler Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)

• TipRanks·08/07 14:00

  Analysts Are Bullish on Top Healthcare Stocks: Relmada Therapeutics (RLMD), Delcath Systems (DCTH)

• TipRanks·08/06 21:41

  Relmada Highlights Q2 Results and NDV-01 Pipeline Progress

• Seeking Alpha·08/06 20:37

  Relmada Therapeutics Non-GAAP EPS of -$0.11